Saturday 17 October 2026
Export XZO’s income statement to Excel — free account
Exzeo Group, Inc.
XZO Financial Insurance Diversified
Exzeo Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $217.0 million, up 62.0% from fiscal 2024. In the quarter to June 2026, revenue grew 3.02%, EPS fell 5.49% and free cash flow fell 59.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
16.65
0.04
−0.24%
Follow XZO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+5 more quarters Free account |
25.84 | 24.17 | 14.74 | 17.21 |
P/S ratio |
9.22 | 8.96 | 5.89 | 6.71 | |
P/FCF ratio |
16.79 | 19.95 | 12.52 | 18.26 | |
P/Operating CF |
56.45 | 172.34 | 50.90 | 96.56 | |
P/B ratio |
22.66 | 7.65 | 4.72 | 5.17 | |
Price to Tangible BV |
22.66 | 7.65 | 4.72 | 5.17 | |
EV/Sales |
8.49 | 7.55 | 4.84 | 6.09 | |
EV/EBITDA |
18.55 | 15.05 | 9.66 | 12.23 | |
EV/Operating CF |
15.02 | 16.34 | 10.05 | 16.16 | |
EV/FCF |
15.46 | 16.82 | 10.28 | 16.58 | |
Quick Ratio |
1.64 | 3.79 | 2.57 | 1.73 | |
Current Ratio |
1.73 | 3.86 | 2.65 | 1.85 | |
Net Debt/EBITDA |
(5.01) | (11.14) | (8.97) | (4.68) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
2.12 | 1.25 | 1.16 | 1.15 | |
Operating CF/Net income |
1.49 | 0.47 | 1.28 | 0.68 | |
Capex/Depreciation |
(1.32) | (0.68) | (0.45) | (0.28) | |
Research and Development Expense of Revenue |
4.52% | 3.30% | 4.15% | 4.22% | |
Selling, General and Administrative Expense of Revenue |
7.07% | 11.55% | 9.39% | 10.02% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
1.33% | 0.89% | 1.33% | 1.31% | |
Graham Net Nets |
0.03 | 0.12 | 0.12 | 0.05 | |
Graham Number |
4.12 | 8.46 | 8.35 | 8.49 | |
Earnings Yield |
3.87% | 4.14% | 6.78% | 5.81% | |
Free Cash Flow Yield |
5.95% | 5.01% | 7.99% | 5.48% | |
Revenue per Share |
0.65 | 0.67 | 0.63 | 0.66 | |
Operating CF per Share |
0.37 | 0.14 | 0.29 | 0.17 | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.36 | 0.14 | 0.28 | 0.17 | |
Cash per Share |
1.67 | 3.81 | 2.62 | 1.55 | |
Shareholders Equity per Share |
0.93 | 3.17 | 3.11 | 3.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.93 | 3.17 | 3.11 | 3.27 | |
Free Cash Flow |
30.30 | 10.88 | 25.15 | 15.21 | |
Working Capital |
68.72 | 241.43 | 162.35 | 77.97 | |
Capital Expenditures |
(1.19) | (0.40) | (0.33) | (0.21) | |
Net Current Asset Value |
58.82 | 232.24 | 156.10 | 72.09 | |
EV/EBIT |
19.05 | 15.46 | 9.93 | 12.56 | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.00 | |
Price to Operating Income |
20.69 | 18.34 | 12.09 | 13.83 | |
| Other line items | |||||
Average Receivables |
— | — | — | 13.92 | |
Average Payables |
— | — | — | 5.25 | |
Average Assets |
91.13 | 173.87 | 189.88 | 192.89 | |
Average Common Equity |
— | — | — | 151.84 |
Columns are period end dates